Women's Health Checkup
Methodology & AI Transparency ⓘ
Women's Health Checkup Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Regular checkups with your health care provider are different from appointments for sickness or injury.
- 2 Real-world patient consensus: Mapped to Preventive Screening & Blood Biomarkers under ICD-10-CM Z01.1 for Women's Health Checkup clinical workups.
- 3 Typical cash cost range: Workup highlights for Women's Health Checkup (Z01.1): evidence-based risk stratification in Women's Health Checkup (Z01.1: pairing lifestyle nutrition/exercise).
- 4 Top reported side effects / signs: Follow-up benchmark in Women's Health Checkup: maintaining CBC, CMP & in Women's Health Checkup (Z01.1: eGFR Baseline) within Within optimal preventive reference intervals (Z01.1).
Ask our AI Specialists anything about Women's Health Checkup
What Is Women's Health Checkup?
Regular checkups with your health care provider are different from appointments for sickness or injury. Your checkups, which are also called well-woman exams, include physical exams as well as preventive care. They can help find health problems early, when they may be easier to treat. Your checkup is usually done by a provider with special training in caring for women. It will include screenings for chronic diseases. As a woman, you may also get special exams and screenings, such as: A pelvic exam to check the health of your reproductive organs. Your provider will look at your vulva, vagina, and cervix.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Women's Health Checkup (code Z01.1) is lipoprotein particle concentration [Women's Health Checkup Z01.1], Cross-referenced with NIH MeSH (Women's Health, Physical Examination), which Preventive Screening & Blood Biomarkers clinicians address while surveilling CBC, CMP & in Women's Health Checkup (Z01.1: eGFR Baseline) (Within optimal preventive reference intervals (Z01.1)).
Common Symptoms & Clinical Signs
- • Birth control or family planning
- • Menstrual concerns
- • Presentation of Women's Health Checkup (Z01.1): subtle fatigue, recovery in Women's Health Checkup (Z01.1: lag, or micronutrient)
- • Secondary Women's Health Checkup clinical sign: age- or family-history-guided in Women's Health Checkup (Z01.1: cancer, vascular, bone,)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Women's Health Checkup Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | Z01.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Preventive Screening & Blood Biomarkers | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: CBC, CMP & in Women's Health Checkup (Z01.1: eGFR Baseline) | Within optimal preventive reference intervals (Z01.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: 25-Hydroxy Vitamin D, in Women's Health Checkup (Z01.1: Ferritin & B12) | 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (Z01.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: ApoB, HbA1c & in Women's Health Checkup (Z01.1: hs-CRP Triad) | ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (Z01.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Women's Health Checkup
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Atazanavir and Cobicistat Evotaz • RxCUI RXN-00033641-2312 | Cytochrome P450 3A Inhibitor | 94% | $51.9394 | $ 185.00 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Women's Health Checkup)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Effect of sildenafil citrate on treatment of infertility in women with a thin: What a 1,452-Participant Study Found Sildenafil citrate is effective in improving endometrial thickness, the clinical pregnancy rate, and the biochemical pregnancy rate in women who have a thin endometrium. The Journal of international medical research • 2020-11-15 • Meta-Analysis | N = 1,452 | 99/100 | PMID 33176524 ↗ |
| New Insights on Metabolic and heart and blood vessel effects of TX-001HR in menopausal women with: What a 1,835-Participant Study Found One episode of deep venous thrombosis and three cases of heart and blood vessel disease were observed, similar to expected rates of these events in the general population. Climacteric : the journal of the International Menopause Society • 2019-12-15 • Randomized Controlled Trial | N = 1,835 | 96/100 | PMID 31364889 ↗ |
| New Insights on Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal: What a 16,071-Participant Study Found These results. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research • 2021-07-15 • Phase III Randomized Trial | N = 16,071 | 96/100 | PMID 33724542 ↗ |
| New Insights on Fezolinetant effect on vasomotor symptoms due to menopause in women unsuitable: What a 1,022-Participant Study Found This pooled analysis demonstrated efficacy of fezolinetant vs. Current medical research and opinion • 2025-02-15 • Randomized Controlled Trial | N = 1,022 | 96/100 | PMID 40044127 ↗ |
| New Insights on Meta-analysis of the effect of metformin treatment on overall mortality rates in: What a 4,723-Participant Study Found Metformin treatment is associated with a significant reduction in OM irrespective of diabetes status in patients with EC. Maturitas • 2017-07-15 • Meta-Analysis | N = 4,723 | 94/100 | PMID 28539171 ↗ |
Women's Health Checkup Patient Community & “People Like Me” Threads
Filter Women's Health Checkup community threads and patient logs by age, biological sex, dosage, and treatment duration.